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Abstract
The sarcoplasmic/endoplasmic reticulum Ca2+ATPases (SERCAs) are the main Ca2+
pumps which decrease the intracellular Ca2+level by reaccumulating Ca2+ into the sarco-
plasmic reticulum. The neonatal SERCA1b is the major Ca2+ pump in myotubes and young
muscle fibers. To understand its role during skeletal muscle differentiation its synthesis has
been interfered with specific shRNA sequence. Stably transfected clones showing signifi-
cantly decreased SERCA1b expression (cloneC1) were selected for experiments. The ex-
pression of the regulatory proteins of skeletal muscle differentiation was examined either by
Western-blot at the protein level for MyoD, STIM1, calsequestrin (CSQ), and calcineurin
(CaN) or by RT-PCR for myostatin and MCIP1.4. Quantitative analysis revealed significant
alterations in CSQ, STIM1, and CaN expression in cloneC1 as compared to control cells.
To examine the functional consequences of the decreased expression of SERCA1b, re-
peated Ca2+-transients were evoked by applications of 120 mMKCl. The significantly higher
[Ca2+]i measured at the 20th and 40th seconds after the beginning of KCl application (112±3
and 110±3 nM vs. 150±7 and 135±5 nM, in control and in cloneC1 cells, respectively) indi-
cated a decreased Ca2+-uptake capability which was quantified by extracting the maximal
pump rate (454±41 μM/s vs. 144±24 μM/s, in control and in cloneC1 cells). Furthermore, the
rate of calcium release from the SR (610±60 vs. 377±64 μM/s) and the amount of calcium
released (843±75 μM vs. 576±80 μM) were also significantly suppressed. These changes
were also accompanied by a reduced activity of CaN in cells with decreased SERCA1b. In
parallel, cloneC1 cells showed inhibited cell proliferation and decreased myotube nuclear
numbers. Moreover, while cyclosporineA treatment suppressed the proliferation of parental
cultures it had no effect on cloneC1 cells. SERCA1b is thus considered to play an essential
role in the regulation of [Ca2+]i and its ab ovo gene silencing results in decreased skeletal
muscle differentiation.
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Introduction
Skeletal muscle development is based on the fusion of myoblasts into a myotube. This multinu-
cleated syntitium contains a complex and sophisticated internal membrane system called sar-
coplasmic reticulum (SR) considered as a specialized form of endoplasmic reticulum (ER;
reviewed by [1]). The SR is an attribute of muscle entity and predominantly regulates calcium
movements during contraction-relaxation cycle; Ca2+ is released from the SR into the sarco-
plasmic space where it triggers muscle contraction then it is reuptaken during the relaxation
period and stored in the SR. There are proteins in the SR specialized for this activity; the main
players being the ryanodine receptor (RyR) through which Ca2+ is released into the sarcoplasm,
the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA) that reuptakes Ca2+ into the
SR from the sarcoplasm, and calsequestrin (CSQ) that binds stored Ca2+ in the SR lumen. The
three main SR proteins are expressed in developmental isoforms in fetal/postnatal stages and
in myotubes of mammals. RyR expressed as RyR3 [2], CSQ as CSQ2/cCSQ [3,4], and SERCA
as SERCA1b [3,4]. The ratio and the functional differences of these proteins compared to the
adult isoforms are not entirely known although it could probably be important for better un-
derstanding the mechanism of muscle differentiation and store-operated calcium entry
(SOCE).
SOCE, the process through which the SR is refilled with Ca2+ from the extracellular source
once its content has been reduced, has been shown to be important in muscle development
[5,6]. This underlying process of muscle differentiation is initiated by one of the stromal inter-
action molecule isoforms, STIM1 serving with its intraluminal part as a calcium sensor within
the ER/SR [7]. In case of low Ca2+-level the luminal part of STIM1 monomers do not bind to
Ca2+ in the ER/SR rather they associate with each other and are transferred to the close prox-
imity of the plasma membrane where they activate Orai1, a channel allowing extracellular
Ca2+-entry into the cell. Subsequently Ca2+ is transferred from the sarcoplasm to the SR by
SERCA pump activity (reviewed by [8]).
The aim of present study was to explore the function of SERCA1b, a major calcium pump
of in vitromyotubes and embryonic/postnatal human and rodent muscles [4,9]. SERCA1b
mRNA is spliced from the transcript of the SERCA1 gene (atp2a1) by skipping exon 22 while
in the adult SERCA1a mRNA each exon remains [10]. Since the first stop codon is in exon 22,
the translation of SERCA1b terminates in exon 23 using the second stop codon. As a result, the
SERCA1b protein has an eight amino acid long tail instead of the C-terminal glycine of the
SERCA1a protein [3]. SERCA1a is expressed in adult fast type skeletal muscle, however, no
functional difference could be observed in the Ca2+ transport and affinity if compared to SER-
CA1b when their corresponding cDNAs are expressed in COS-1 cells [11]. SERCA1 knock-out
mice (expressing neither SERCA1a nor SERCA1b) die in respiratory failure and cyanosis short-
ly after birth probably because of insufficient function and development of the diaphragm [12],
which has been shown to express SERCA1b as the main SERCA1 isoform in neonatal mice [4].
Interestingly, the expression of SERCA1b is under strict posttranscriptional control; although
its mRNA is upregulated in stretch [13] and denervation [14] of adult muscle, the protein is ex-
pressed only in developing or regenerating muscle independently of whether it is becoming a
slow or fast type [4].
The function of SERCA1b has partially been uncovered by injecting regeneratingm. soleus
of the rat with a plasmid expressing an shRNA targeted against its mRNA [15]. Although less
than 1% of the fibers and even less than 0.1% of the myonuclei were successfully transfected
[16] it remarkably stimulated growth also in the non-transfected fibers and in the entire regen-
erating muscle. Apparently this effect was initiated from the transfected fibers through auto-
crine-paracrine mechanisms probably through the calcineurin-NFAT-interleukin4 pathway
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because it was independently prevented by co-transfection with a calcineurin(CaN) inhibitor
cain/cabin expressing vector and the perimuscular injection of interleukin4 (IL4) antibody.
However, the decline of SERCA1b in the above study could only be demonstrated by immuno-
histochemistry in about 25% of the shRNA transfected fibers. It has also been show recently
that the SERCA1a is bound and activity-stimulated by the stromal interactive molecule 1
(STIM1) in primary mouse myotubes [17]. As SERCA1b has the entire SERCA1a sequence ex-
cept the C-terminal glycine [3] and is the dominant SERCA1 in mouse myotubes this also un-
derline the importance of this neonatal Ca2+ pump.
Our hypothesis was that SERCA1b is an essential contributor to myotube development and
other myogenic processes. Experiments were, therefore, conducted to explore the cellular ef-
fects of stable SERCA1b silencing in the myogenic C2C12 cells on the expression of proteins
involved in calcium handling, on calcium homeostasis, and on muscle differentiation. SER-
CA1b was successfully silenced in 75% of stably transfected clones. The results presented here
are complementary to the SERCA1b silencing in regenerating muscle [15] and show for the
first time the importance of the neonatal calcium pump in calcium handling, proliferation, and
myotube development of myogenic cells.
Materials and Methods
Cell cultures and transfection
C2C12 mouse skeletal muscle cell line was obtained from the European Collection of Cell Cul-
tures (ECACC). The cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM;
Sigma-Aldrich, St. Louis, MO, USA) supplemented with 10% fetal bovine serum(FBS), 50 U/ml
penicillin, and 50 g/ml streptomycin and were incubated at 37°C in an atmosphere of 95% air
and 5% CO2 and 80% humidity in a humidified incubator (according to the instructions of the
supplier). RNA interference was applied in order to reduce endogenous SERCA1b expression.
The sequence targeted for SERCA1b silencing was 5-ctatctggaggatccagaa-3 (S1A Fig), corre-
sponding to the last 11 bases of exon 21 (3121–3131b of the mouse SERCA1 cDNA, acc. No.
NM_007504) and the first 8 bases of exon 23 (3174–81b). These fragments are contiguous only
in the spliced SERCA1b mRNA after skipping exon 22. The chosen shRNA cassette sequence
besides the sense (5’ctatctggaggatccagaa) and antisense (5’ttctggatcctccagatag) region contains a
loop and termination sequence resulting in a hairpin siRNA. Blast filtering ensured that this se-
quence has homology only with SERCA1b and not with any other known gene. Scrambled
shRNA was used to demonstrate that the target specific shRNA did not induce a nonspecific ef-
fect on gene expression. These shRNA sequences were cloned into pLKO.1-puro-CMV-tGFP
expression vector. Stable transfection was performed in Opti-MEM reduced serum content
medium using Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA, USA) for 2.5 h at 37°C.
Cells were allowed to express the introduced sequence for 48 h in growth medium then were
selected in DMEM containing 1.5 μg/ml puromycin. After 14–15 days, single colonies were iso-
lated and experiments were carried out on separated clones of SERCA1b transfected cells. Pool
of scrambled shRNA transfected and non-transfected parental cells were used as control. Dif-
ferentiation of non-transfected, and transfected cells was induced at 80% confluency by ex-
changing the culture medium for DMEM supplemented with 5% horse serum (HS), 2% FBS
and penicillin–streptomycin. The efficiency of SERCA1b gene silencing was monitored at pro-
tein level by Western-blot using a specific anti-SERCA1b antibody corresponding to the termi-
nal octamer of the protein. Functional experiments were carried out on 5-day-old
differentiated myotubes of parental and transfected cultures.
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Immunostaining
Cultured cells were washed with ice-cold phosphate-buffered saline (PBS; 0.02 M NaH2PO4,
0.1 M NaCl), fixed with −20°C 100% methanol for 15 min, permeabilized with 0.1% Triton X-
100 in PBS for 10 min, and blocked with 1% bovine serum albumin (BSA) diluted in PBS
(blocking solution) for 30 min at room temperature. Cells were then incubated for 4 hours at
4°C with the anti-desmin primary antibody (dilution was 1:500 in blocking solution). Then
fluorescein (FITC) labeled anti-mouse secondary antibody was applied for 1 h at room temper-
ature. Vectashield mounting medium with DAPI (Vector Laboratories, Burlingame, CA, USA)
was used for visualization of nuclei. Images were taken using LSM 510 META confocal micro-
scope (Zeiss, Oberkochen, Germany).
Preparation of cell extracts
On the 5th day of differentiation cells in cultures were washed with ice-cold PBS, harvested in
homogenization buffer (20 mM Tris–Cl, 5 mM EGTA, 1 mM 4-(2-aminoethyl) benzenesul-
phonyl fluoride, 20 μM leupeptin, pH 7.4; all from Sigma) and disrupted by sonication on ice.
Protein content of the samples was measured by a modified bicinchoninic acid (BCA) protein
assay (Pierce, Rockford, IL, USA) using BSA as a standard.
For SERCA2a detection, on the 5th day of differentiation cells in cultures were washed with
ice-cold PBS, harvested in PBS and collected by centrifugation. The cells were washed twice
with cold PBS. The supernatant were removed and discard, and collected the cell pellet. The
cell pellet were lysed in cell lysis buffer (50 mM Tris–Cl, 5 mM EDTA, 250 mMNaCl, 50 mM
NaF, 1 mM sodium orthovanadate, 1% Nonidet P40, 0.02% sodium azide, pH 7.4; all from
Sigma) for 30 minutes, on ice, with vortexing at 10 minute intervals. The cell lysis buffer was
supplemented with 1 mM phenylmethylsulfonyl fluoride (PMSF; 0.3 M stock in DMSO) and
protease inhibitor cocktail. The extract were transferred to microcentrifuge tubes and centri-
fuged at 13,000 rpm for 10 minutes at 4°C. The clear lysate was measured by a modified
bicinchoninic acid (BCA) protein assay (Pierce, Rockford, IL, USA) using BSA as a standard.
Heat denaturation was applied at 80° C for 5 min
SDS–PAGE andWestern blot analysis
Total cell lysates were examined by Western-blot analysis. Samples for SDS–PAGE were pre-
pared by the addition of 1/5 volume of 5-fold concentrated electrophoresis sample buffer
(310 mM Tris–HCl, pH 6.8; 10% SDS, 50% glycerol, 100 mM DTT, 0.01% bromophenol blue)
to cell lysates and boiled for 5 min at 80°C. 30 μg of protein was separated by 7.5% SDS–PAGE
gel for immunological detection of examined proteins. Samples were transferred electrophoret-
ically to nitrocellulose membranes (Bio-Rad Laboratories, CA, USA). After blocking with 5%
non-fat dry milk in PBS, membranes were incubated with the appropriate primary antibodies
overnight at 4°C (see Table 1). After washing three times for 10 min with PBST (PBS supple-
mented with 0.1% Tween 20), membranes were incubated with a secondary antibody, peroxi-
dase-conjugated goat anti-rabbit, and anti-mouse IgG (BioRad) in 1:1000 dilution in PBS
containing 5% non-fat dry milk for 1 h. Signals were detected by enhanced chemiluminescence
(ECL) reaction (Thermo Scientific, Rockford, IL USA). The quantitative analysis was per-
formed using the original images of the membranes. The intensity of the specific bands and
the background from the same image were measured by ImageJ. The background values were
then substracted. The values were normalized to those obtained for actins of the same samples.
These data were then expressed as relative to control or scrambled. Measurements were carried
out in 3 independent experiments.
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mRNA expression analysis using reverse transcription followed by PCR
(RT-PCR)
For RT-PCR analysis, colonies were washed three times with ice cold PBS, snap-frozen in liq-
uid nitrogen and stored at −70°C. Total RNA was isolated from myotubes using Qiagen
RNeasy Mini Kit according to the instructions of the manufacturer (Qiagen, Valencia, CA
USA). Assay mixture (20 μl) for reverse transcriptase reaction (Omniscript, Qiagen) contained
500 ng RNA, 0.25 μl RNase inhibitor, 0.25 μl oligo (dT), 2 μl dNTP (200 μM), 1 μl M-MLV RT
in 1 × RT buffer. Amplifications of specific cDNA sequences were carried out using specific
primer pairs that were designed by Primer Premier 5.0 software (Premier Biosoft, Palo Alto,
CA, USA) based on human nucleotide sequences published in GenBank and purchased from
Integrated DNA Technologies, Inc. (IDT; Coralville, IA, USA). The specificity of custom-de-
signed primer pairs was confirmed in silico by using the Primer-BLAST service of NCBI
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/). Nucleotide sequences of forward and re-
verse primers and reaction conditions are shown in Table 2. PCR reactions were allowed to
proceed in a final volume of 50 μl (containing 2 μl forward and reverse primers, 1 μl dNTP
(200 μM), and 0.5 μl Promega GoTaq DNA polymerase (in 1 × reaction buffer) in a program-
mable thermocycler (Thermal Cycler C1000, Bio-Rad) with the following settings: 2 min at
95°C for initial denaturation followed by repeated cycles of denaturation at 94°C for 1 min,
Table 1. List of antibodies using for the detection of different proteins playing important role of calcium homeostasis and differentiation of skeletal
muscle
name commercial supplier catalog
number
host source dilutions epitope
MyoD Santa Cruz sc-377460 mouse monoclonal 1/200 amino acids 1–318 of MyoD of mouse origin
SERCA1b Zádor E. Univ. of Szeged rabbit monoclonal 1/800 terminal octamer of rat SERCA1b
SERCA1 Thermo Scientiﬁc MA3-912 mouse monoclonal 1/1000 amino acid 506-C-terminus of rabbit skeletal muscle
ATPase
SERCA2a F. Wuytack Univ. of
Rotterdam
rabbit monoclonal 1/20000 amino acid 989–997 of pig SERCA2a isoform
Calcineurin Cell Signaling 2614S rabbit polyclonal 1/1000 carboxy terminus of human calcineurin (PP2B)
Calsequestrin Thermo Scientiﬁc PA1-913 rabbit polyclonal 1/1000 puriﬁed canine cardiac calsequestrin
STIM1 BD Laboratories 610954 mouse monoclonal 1/500 amino acid 25–139 human
Actin Santa Cruz sc-1616 rabbit polyclonal 1/500 C-terminus of Actin of human origin
Desmin Sigma Aldrich D1033 mouse monoclonal 1/500 pig stomach was used as the immunogen
Anti-Cav pan alomone ACC-004 rabbit polyclonal 1/200 C-terminus of rat Cav1.2
doi:10.1371/journal.pone.0123583.t001
Table 2. Nucleotide sequences, amplification sites, GenBank accession numbers, annealing temperatures and amplicon sizes for each primer
pair are shown.
Gene Primer Nucleotide sequence (5’!3’) GenBank ID Annealing temperature Amplicon size (bp)
Skeletal muscle differentiaion
Myostatin sense ACTGGAATCCGATCTCTGAAACTT (665–688) NM_010834 58.0°C 233
antisense GACCTCTTGGGTGTGTCTGTCAC (897–875)
MCIP1.4 sense AAGGAACCTCCAGCTTGGGCT (25–45) NM_019466.3 60.0°C 160
antisense CCCTGGTCTCACTTTCGCTG (184–165)
Control Housekeeping gene
GAPDH sense AAGGTCGGAGTCAACGGATTTGG (99–121) NM_001289726.1 56.0°C 322
antisense AATGAGCCCCAGCCTTCTCCAT (420–399)
doi:10.1371/journal.pone.0123583.t002
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primer annealing for 60 s at an optimized temperature for each primer pair (see Table 2) and
extension at 72°C for 1 min 30 s. After the final cycle, further extension was allowed to proceed
for another 10 min at 72°C. PCR products were analyzed using 1.5% agarose gel at 100 V
constant voltage.
Single cell fluorescent Ca2+-measurements
Measurements were performed using the calcium-dependent fluorescent dye Fura-2 as de-
scribed previously [18]. Briefly, differentiated C2C12 skeletal muscle cultures were transferred
to 1 mL fresh DMEM containing 5 μL Fura-2-acetoxy-methylester (AM; 10 μM; Life Technolo-
gies, Carlsbad, CA, USA) and 3 μL neostigmin (0.3 nM; to inhibit extracellular choline-esterase
activity; TEVA, Debrecen, Hungary) and incubated in a CO2 incubator at 37°C for 1 h. Fura-
2-loaded cells were then placed on the stage of an inverted fluorescent microscope (Diaphot;
Nikon, Kowasaki, Japan) and viewed using a 40× oil immersion objective. Calcium imaging
was performed in normal Tyrode’s solution (NTY; containing in mM, 137 NaCl, 5.4KCl,
0.5 MgCl2, 1.8 CaCl2, 11.8 HEPES; 1 gL
–1 glucose; pH 7.4). KCl was applied in 120 mM final
concentration in NTY by replacing an equal amount of NaCl. The sarcoplasmic/endoplasmic
reticulum Ca2+-ATPase (SERCA) inhibitor cyclopiazonic acid (CPA) (10 μM) was diluted in
Ca2+-free Tyrode’s solution (stock: 10 mM in DMSO). Cells were continuously washed with
NTY using a background perfusion system excitation wavelength was altered between 340 and
380 nm (F340 and F380) by a microcomputer-controlled dual-wavelength monochromator
equipment (DeltaScan; Photon Technologies International, New Brunswick, NJ, USA). Emis-
sion was detected at 510 nm at 10 Hz acquisition rate using a photomultiplier. Background
fluorescence was subtracted on-line from F340 and F380 signals by the data acquisition software.
Intracellular [Ca2+] was calculated from the ratio of measured fluorescence intensities
(R = F340/F380) as described by Grynkiewicz and colleagues [19]. The measuring bath was con-
stantly perfused with NTY at a rate of 2 mLmin–1 (EconoPump; Bio-Rad Laboratories, CA,
USA). Test solutions were directly applied to the cells through a perfusion capillary tube (Per-
fusion Pencil; AutoMate Scientific, San Francisco, CA, USA) with an internal diameter of
250 μm at a rate of 1.5 μLs–1, using a local perfusion system (Valve Bank 8 version 2.0, Auto-
Mate Scientific). All measurements were performed at room temperature.
Calculation of [Ca2+]i and the activity of Ca
2+-pump
[Ca2+]i was calculated from the ratio of fluorescence intensities (R = F340/F380) using an in vivo
calibration (Rmin = 0.2045, Rmax = 8.315, Kd × β = 1183 nM). To determine the activity of the
Ca2+ pump and the Ca2+ flux entering the myoplasmic space, the Ca2+ binding to intracellular
binding sites and the removal of Ca2+ from the intracellular space was modeled as presented in
earlier reports [20,21]. In brief, Ca2+ binding to intracellular sites— to the SERCA pump, to
troponin C, to parvalbumin, and to the dye—and the removal were considered. The computer
routine determined, as a single best fit parameter, the maximal transport rate of the Ca2+ pump
(PVmax) from the declining phase of the Ca
2+ transient following the stimulation. All other pa-
rameters in the model were held constant at values taken from the literature. The amount of
calcium released from the SR was calculated as the sum of all calcium bound to myoplasmic
binding sites and that transported by the SERCA pump [22].
Examination of cell proliferation and differentiation
Cultures of C2C12 cells were photographed daily from the 1st to the 5th day after seeding using
a Canon EOS-300D (Canon Corp., Japan) digital single lens reflex camera mounted on a phase
contrast microscope. Culturing was performed in parallel in the presence of 200 nM
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cyclosporineA (CSA), solution was changed every 2nd day. Photos of five fields of view per cul-
ture were taken every day. Myogenic nuclei were marked manually and morphometric analysis
was done on these images. Cell proliferation was characterized by the increase in the number
of myogenic nuclei normalized to the value obtained after 24 hours of culturing. To detect the
quantitative parameters of differentiated myotubes 15–15 random fields of view were exam-
ined from 3 independent culturing (40x oil immersion objective, confocal laser scanning mi-
croscope). Cultures on the 5th day of differentiation were fixed, and the number of DAPI-
stained nuclei were counted manually, the diameter was measured by Image Browser.
Calcineurin activity assay
For in vitro CaN activity assays, cells were washed in physiological NaCl solution and were har-
vested. After centrifugation, cell pellets were suspended in 100 μL of homogenization RIPA
(Radio Immuno Precipitation Assay)-buffer (150 mM sodium chloride, 1.0% NP40, 0.5% sodi-
um deoxycholate; 50 mM Tris, pH 8.0) containing protease inhibitors (Aprotinin (10 ug/mL),
5 mM Benzamidine, Leupeptin (10 μg/mL), Trypsine inhibitor (10 μg/mL), 1 mM PMSF,
5 mM EDTA, 1 mM EGTA, 8 mMNa-Fluoride, 1 mM Na-orthovanadate). Samples were
stored at—70°C. Suspensions were sonicated using pulsing bursts for 30 s at 40 A (Cole-
Parmer, Illinois, USA). After centrifugation at 10,000×g for 10 min at 4°C, supernatants with
equal protein concentrations were used for enzyme activity measurements. Activity of calci-
neurin was assayed by using RII phosphopeptide substrate, and the release of free PO4
3- was
detected by a classic malachite green assay (Abcam, Cambridge, UK). Six separate wells were
used from every single experimental group. Measurements were performed according to the in-
structions of the manufacturer in two independent experiments.
Statistical analysis
All data are representative of at least three independent experiments. Averages are expressed as
mean ± SEM (standard error of the mean; n, number of cells measured). Statistical analysis was
performed by using Student’s t-test. Threshold for statistically significant differences as com-
pared to respective control cultures was set at p<0.05.
Results
Cell culturing and transfection
The neonatal isoform SERCA1b is the major Ca2+-pump in myotubes and in muscle fibers
from young animals [4,23]. The effect of SERCA1b silencing was thus examined in a mouse
skeletal muscle cell line. SERCA1b protein synthesis has been interfered with using a specific
shRNA sequence cloned into pLKO.1-puro-CMV-tGFP expression vector. Decreased protein
expression was confirmed in the selected clones using a SERCA1b specific antibody at the myo-
tube stage. As demonstrated in Fig 1A four of the six clones (C1, 3, 4, and 5) displayed marked
suppression in SERCA1b expression. To investigate the possible compensatory overexpression
of SERCA1a,– the adult sarcoplasmic reticulum ATPase isoform –, another antibody recogniz-
ing a common epitope of SERCA1a and SERCA1b was applied (Fig 1B). According to our ob-
servations the SERCA1 positivity was similar to SERCA1b expression pattern. Quantitative
analysis of the Western-blots confirmed a very pronounced decrease in SERCA1b expression
in certain identified clones compared to that of scrambled shRNA transfected cells (S1B Fig).
CloneC1 and another clone (C5)– in which SERCA1b was downregulated to a lesser extent—
were selected for further experiments (optical density values were 6.6±0.8% in cloneC1 and
14.7±1.9% in cloneC5 expressed as relative to that of scrambled shRNA transfected cells).
SERCA1b and Muscle Differentation
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Scrambled shRNA transfected cells were used as a control. All the experiments were performed
on multinucleated, terminally differentiated myotubes on the 5th day of differentiation.
Reduced SERCA1b expression alters the expression of proteins
involved either in the Ca2+-homeostasis or differentiation of skeletal
muscle
Next the expression level of calsequestrin (CSQ)– the main Ca2+-binding protein inside the
sarcoplasmic reticulum of skeletal muscle –and the stromal interacting molecule1 (STIM1)–
the calcium sensor of SOCE in the SR—were studied by Western-blot analysis. The scrambled
shRNA transfection did not modify the expression level of CSQ while, in the cloneC5 myotubes
the expression showed a moderate decrease. Furthermore, in cloneC1 cells only a very weak
band could be detected (Fig 1C). Similarly, STIM1 expression was slightly reduced in scram-
bled shRNA transfected and cloneC5 cells as compared to the parental cells, while the STIM1
expression was hardly detectable in cloneC1 (Fig 1D). Expression pattern of the main regulato-
ry proteins that play an essential role in skeletal muscle differentiation were examined byWest-
ern-blotting and RT-PCR analysis. MyoD, and CaN were clearly detectable at protein level.
The expression of the myogenic transcription factor (MyoD) was found to be unaffected. On
the other hand, the calcium dependent phosphatase calcineurin showed a remarkable decrease
in cloneC1 and even in cloneC5, as compared to control cell types (Fig 2A and 2B). Quantita-
tive analysis of the results after normalizing to actin also confirmed the significant alterations
in CSQ, STIM1, and CaN expression detected in cloneC1 as compared to control cells (S1C–
S1F Fig). On the other hand, DHPR expression was similar in transfected and parental C2C12
cells (S2F Fig).
Using specific SERCA2a antibody to detect the isoform corresponding to the Ca2+pump in
slow skeletal and cardiac SR, a band was detected with similar intensity at ~115 kDa in all
C2C12 types. In mouse heart the SERCA2a positivity showed the adequate expression. (S2D
and S2E Fig).
Using specific primer pairs, an mRNA transcript analysis of myostatin, – a negative regula-
tor of skeletal muscle differentiation—and the modulatory calcineurin interacting protein,
MCIP1.4 was performed. Amplimers of expected sizes were identified for all the available
mRNAs, and myostatin showed a significantly decreased mRNA expression in cloneC1 as
compared to scrambled shRNA transfected cells, thus the myostatin transcript level correlated
with the SERCA1b silencing. In parallel MCIP1.4 was proved to be statistically modified in clo-
neC1 (Fig 2D and 2E). The optical density values of specific signals were normalized to
GAPDH expression (S2A and S2B Fig; for raw data see Supporting Information—S1 Raw
data).
Fig 1. Effect of SERCA1b shRNA on the expression pattern of proteins involved in Ca2+-homeostasis.
Examination of decreased SERCA1b expression in C2C12 myotubes. (A-B) Protein expression of SERCA
was detected byWestern-blot analysis to prove the efficiency of SERCA1b-specific shRNA in multinucleated
myotubes. Different stably transfected clones, pool of the clones and scrambled shRNA transfected cells
were compared. The 115 kDa isoforms were detected either by SERCA1b specific antibody corresponding to
the terminal octamer of the protein or by an antibody recognizing both SERCA1a and b isoforms. Actin was
used as a control. (C) Western blot analysis to detect the SR calcium-binding protein (calsequestrin)
expression in selected cloneC1, C5, scrambled shRNA transfected, and parental cells. (D) Western-blot
analysis showing the protein level of the key molecule of SOCE (STIM1). Total protein samples were used
(30 μg in each lane) to examine the protein expression level. For preparing protein samples cultures were
harvested on the 5th day of differentiation in each cases. Representative data of 3 independent experiments.
doi:10.1371/journal.pone.0123583.g001
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Fig 2. SERCA1b silencingmodifies the proteins responsible for differentiation. Effect of decreased
SERCA1b protein level on the expression pattern of key proteins involved in skeletal muscle differentiation.
(A-C) Western-blot analysis to detect the main differentiation marker proteins (MyoD, and Calcineurin) on the
5th day of differentiation. Total protein samples were used (30 μg in each lane) to examine the protein
expression level. Representative data each of 3 independent experiments. Actin was used as a control. (D-E)
mRNA expression pattern of myostatin and MCIP 1.4 was assessed by RT-PCR reaction using specific
primers and detected at the expected size. GAPDH was used as a control. (F) Activity of calcineurin was
assayed by using RII phosphopeptide substrate, and the release of free PO4
3- was detected by the malachite
green assay. Six separate wells were used from every experimental group. Measurements were carried out
in two independent experiments. Asterisks (*) mark significant (P<0.05) differences between cells.
doi:10.1371/journal.pone.0123583.g002
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Having confirmed the decreased expression of calcineurin, next the functionality of the pro-
tein was investigated. The application of a CaN activity assay revealed the significantly reduced
activity of calcineurin in line with its decreased expression (Fig 2F).
Effect of reduced SERCA1b expression, on Ca2+-homeostasis
To examine the possible alteration of E-C coupling and the depolarization induced Ca2+-re-
lease from the SR following SERCA1b gene silencing, repeated Ca
2+
-transients were evoked by
the applications of 120 mM KCl in scrambled shRNA transfected and cloneC1 myotubes (Fig
3A and 3B). Neither the amplitude of the transients (681±105, n = 10 vs. 668±128 nM, n = 10
in control and in cloneC1 cells, respectively) nor their rate of rise (606±108 μM/s vs. 489±
149 μM/s, respectively) were significantly altered (p>0.5) in cloneC1 myotubes (Fig 3C and
3D).
To analyze the functional effects of decreased SERCA1b expression, the return of [Ca2+]i to
its resting value following the KCl-evoked transients and the maximal transport rate of the
Ca2+ pump (PVmax) were compared in scrambled shRNA transfected and cloneC1 and C5
myotubes. There was no difference in the resting [Ca2+]i before the transients (108±4 nM in
scrambled shRNA transfected and 109±4 nM in cloneC1 myotubes). However, following the
KCl-evoked transients [Ca2+]i declined slower and returned to a significantly higher level in
the clone C1 myotubes (Fig 4A and 4B; note the different time scales and the insets).
A significantly higher [Ca2+]i could be measured 20 and 40 seconds after the beginning of
KCl application (112±3 nM, and 110±3 in control, while 150±7 nM and 135±5 in cloneC1
cells, respectively) indicating a decreased Ca2+-uptake capability of the SERCA pumps (Fig
4C). This was further quantified by extracting PVmax(maximal transport rate of the pump; see
Materials and methods), which was clearly decreased (p<0.01) in cloneC1 myotubes (144±
24 μM/s) and in cloneC5 myotubes (382±16 μM/s) as compared to scrambled shRNA trans-
fected cells (454±41 μM/s) in line with the decreased expression of SERCA (Fig 4D).
It should be noted that despite of the significantly reduced removal rate of calcium from the
myoplasmic space in cloneC1 cells (see values of PVmax above) the amplitude of the calcium
transients in control and shRNA transfected cells were essentially identical (Fig 3C). In addi-
tion a slight reduction in the maximal rate-of-rise of KCl-evoked calcium transients was also
observed (Fig 3D). These findings can only be reconciled if the amount of calcium released
from the SR was reduced in cloneC1 cells. To test this hypothesis the Ca2+ release flux and the
amount of calcium released were compared in scrambled shRNA transfected and cloneC1
C2C12 myotubes (Fig 5A and 5B). The calcium flux (610±60 vs. 377±64 μM/s, respectively)
were suppressed significantly (p<0.01) as a result of SERCA1b silencing. Furthermore, the cal-
culated integral for the releasable calcium (Fig 5C and 5D) was also proved to be significantly
lower in cloneC1 myotubes as compared to scrambled shRNA transfected cells (843±75 μM vs.
576±80 μM; p<0.02). These observations suggest that the Ca2+-content of the SR and, conse-
quently, the rate of Ca2+-release into the cytosol was decreased when the SERCA1b expression
was interfered with (Fig 5E). To confirm this claim, further experiments were carried out.
When the SERCA blocker CPA (10 μM) was administered to cells in Ca2+ free Tyrode’s, a pro-
nounced elevation in resting Ca2+ levels was observed, caused by Ca2+ release from the SR via
RyRs and concurrent inhibition of Ca2+ re-uptake (Fig 6A and 6B). From these data, the releas-
able Ca2+ content of internal Ca2+ stores could be calculated, which was significantly lower
in C1 cells compared to scrambled shRNA transfected myotubes (5.8±1.1 μMs and 15.7±
1.8 μMs; p<0.001) (Fig 6C) (for raw data see Supporting Information—S2 Raw data).
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Fig 3. Functional effects of SERCA1b-specific shRNA transfection on depolarization-evoked calcium transients in C2C12myotubes.
Representative records of calcium transients evoked by repetitive application of 120 mM KCl in scrambled (A) and in SERCA1b-specific shRNA transfected
(B) C2C12 myotubes (cloneC1). Calcium transients were detected in 1.8 mMCa2+-containing Tyrode’s solution. (C-D) Pooled data of amplitudes and rates-
of-rise of transients (calculated as maximal d[Ca2+]i/dt) evoked by 120 mM KCl. Numbers in parentheses indicate the number of cells measured. Data
represent mean ± standard error of the mean (SEM).
doi:10.1371/journal.pone.0123583.g003
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Fig 4. Detection of altered activity of the SERCA pump due to the decreased SERCA1b expression.Representative records showing the difference in
maximal transport rate of the Ca2+ pump (PVmax) from the declining phase of the Ca
2+-transient following the KCl-induced depolarization (A) in scrambled
and (B) in SERCA1b-specific shRNA transfected C2C12 myotubes (cloneC1). (C) Mean values of [Ca2+]i before and after the transients, demonstrating that
SERCA1b and Muscle Differentation
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SERCA1b silencing modifies the growth of differentiating skeletal
muscle
Morphological alterations of the cells in culture with decreased SERCA1b expression were also
observed during the proliferation and differentiation period, and were compared to those
transfected with the scrambled shRNA. Multinucleated myotubes were treated with anti-des-
min primary antibody and visualized with FITC conjugated secondary antibody (Fig 7A and
7C). Quantitative parameters of myotubes cultured under the same conditions were analyzed
on the 5th day after exchanging the proliferating medium to differentiating medium which cor-
responded to the terminal stage of differentiation. The diameter of terminally differentiated
cloneC1 myotubes did not differ significantly (p>0.2) from that of the control (Fig 7B). In con-
trast, the average number of nuclei was significantly decreased (5.7±0.5 in scrambled shRNA
transfected cells and 3.6±0.2 in cloneC1 cells, p<0.01, Fig 7D). In line with this result, myo-
tubes containing 5 or more nuclei could be detected in a lower ratio than it was observable in
control cultures (Fig 7F). These results confirmed the observations obtained visually, that is,
decreased SERCA1b expressing C2C12 cells form less differentiated myotubes. To investigate
the proliferation rate, 10,000 cells were plated on the 0th day of culturing. On the 4th day of cul-
turing the rate of proliferation— the number of myogenic nuclei normalized to that counted
on the 1st day—was significantly lower (p<0.05) in the cloneC1 cultures, as compared to pa-
rental cells (3.7±1.1 and 9.1±0.7, respectively; Fig 7E), indicating that these cells were dividing
at a slower rate (for raw data see Supporting Information—S3 and S4 Raw data).
Since the expression and activity of CaN was found to be reduced in cloneC1 myotubes, the
effect of CSA was investigated on the rate of proliferation of C2C12 cells (S2C Fig). CSA signifi-
cantly inhibited the proliferation of parental cells as indicated by the relative number of myo-
genic nuclei on the 4th day (9.1±0.7 vs.5.6±0.6; in control and CSA treated cells, respectively;
p<0.05). On the other hand, CSA did not further decrease the rate of proliferation in cloneC1
cultures (3.6±0.5 vs. 3.7±1.1; in CSA treated and non-treated cloneC1 cells, respectively;
p>0.4) indicating that the reduced proliferation seen in these cells was likely to be the conse-
quence of their suppressed CaN activity (for raw data see Supporting Information—S5 Raw
data).
Discussion
The neonatal sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA1b) was successfully
silenced in several clones of the mouse myogenic cells stably transfected with shRNA express-
ing vector. Because of the close homology between mouse and rat the sequence of shRNA was
the same as the one which induced growth stimulation during the regeneration of rat soleus
muscle after being transfected by a plasmid in a previous study [15]. Since the transfection of
regenerating rat muscle was effective only in a few fibers the silencing could not be controlled
in the whole muscle extract only by SERCA1b immunostaining in the fibers and this method
was difficult to evaluate quantitatively [15]. Apart from this, the efficiency of silencing was
demonstrated at the mRNA level by co-expressing SERCA1b and the shRNA in COS-1 cells
[15]. Therefore the present work provides the first clear evidence that the sequence spliced to-
gether from exon 21 and 23 of the SERCA1 transcript can be targeted for efficient silencing of
the neonatal SR Ca2+-pump protein in myogenic cells. The immunoblot signal of total
following the transients [Ca2+]i declined slower and returned to a significantly higher level in cloneC1 compared to scrambled shRNA transfected cells. (D)
Pooled data of SERCA pump activity in selected cloneC1, C5, and scrambled shRNA transfected cells. Numbers in parentheses indicate the number of cells
measured. Asterisks (*) and Hashmarks (#) mark significant (P<0.01) differences between cells bathed in standard Tyrode’s solution.
doi:10.1371/journal.pone.0123583.g004
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Fig 5. Effect of SERCA1b downregulation on releasable calciummeasured on depolarization-evoked calcium transients.Representative records of
calcium release flux (the amount of calcium entering the cytosol in one second) of (A) scrambled shRNA transfected and (B) cloneC1myotubes.
Representative records of the amount of calcium released from SR of (C) scrambled shRNA transfected and (D) cloneC1myotubes. (E) Pooled data of
calcium flux and released calcium in scrambled shRNA transfected and cloneC1 cells. Numbers in parentheses indicate the number of cells measured.
Asterisks (*) mark significant (P<0.05) differences.
doi:10.1371/journal.pone.0123583.g005
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Fig 6. Comparison of releasable calcium. Internal Ca2+ stores of cells were depleted by the application of
10 μMCPA in Ca2+-free Tyrode’s, which caused an increase in [Ca2+]i.both (A) in scrambled shRNA
transfected and (B) cloneC1 cells. (C) Mean values of the integral of CPA induced calcium transients.
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SERCA1 declined in parallel with that of SERCA1b in C2C12 cells, showing that the expression
of the other muscle specific SERCA1 isoform, SERCA1a is not upregulated in compensation
for the SERCA1b silencing. This is in accordance with an earlier work showing that SERCA1b
is the only considerable SERCA1 isoform in C2C12 cell line [4]. It is also important to note
that the expression of the adult and neonatal splice isoforms are under strict translational con-
trol in developing or regenerating rodent muscle; practically no SERCA1a protein is found in
myoblasts and myotubes and, vice versa, no SERCA1b protein has been found in denervated or
stretched adult muscles in spite of its increased mRNA level [4].
The other muscle specific SR calcium pump in C2C12 cells, SERCA2a is expressed from a
different gene (atp2a2), however, its expression level was again not elevated in response to SER-
CA1b silencing. The later phenomenon again complies with the observation that not SERCA2a
but SERCA1b protein level increases significantly at the time of myotube development in both
regenerating slow (m. soleus) and fast type (m. EDL) muscles [4,24,25]. The fusion of myoblasts
into myotubes is paralleled with ER/SR maturation (reviewed by [8]). SERCA1b is found at a
low level in myoblasts but its expression is much higher in C2C12 myotubes suggesting its im-
portance in myotubes and SR development [4]. Myoblasts, as most other cell types express
SERCA2b which has a lower ATPase activity and a higher affinity for Ca2+ than the slow mus-
cle specific isoform SERCA2a spliced from the transcript of the same gene [26,27,28], reviewed
by [28]. Because of its higher Ca2+ transporting capacity and Ca2+-dependence, SERCA2a is a
more relevant pump to reduce the elevated intracellular Ca2+ level than SERCA2b. However,
SERCA2a has about half of the Ca2+ transport capacity and ATPase activity of SERCA1a as
demonstrated in COS-1 cells [29]. Interestingly, no such differences have been found between
SERCA1a and SERCA1b in these cells [11]. This might partially explain why SERCA1b and
not SERCA2a protein content is elevated at the time of myotube development in both slow and
fast regenerating muscle [24,25].
When the ER/SR is filled up with calcium from the extracellular source by SOCE (reviewed
by [8]), the elevation of myoplasmic calcium level is slower but more sustained than in case of
excitation-contraction coupling and it is able to activate calcineurin, a serine threonine phos-
phatase [30]. CaN in turn dephosphorylates transcription factors, as NFAT isoforms and in-
ducing their translocation into the nucleus where they activate muscle specific differentiation
genes [30,31]. Accordingly, the level and activity of the calcium-dependent calcineurin was
also decreased even in a less (C5) not just in the most silenced clone (C1). However, the
MCIP1.4 mRNA level, produced from a CaN-target gene and used as an activity marker of
CaN [32,33,34] declined only in the most effectively SERCA1b silenced (cloneC1) myotubes
indicating an indirect and less prompt response than CaN. CSQ, the main Ca2+-binding pro-
tein in the SR lumen also declined only in the most silenced clone (C1) implicating a lower
need of binding SR Ca2+ (Fig 8).
STIM1, a key element of SOCE is also crucial for muscle development since STIM1 defective
myotubes are lower in number, have low levels of SR Ca2+, and fatigue rapidly [7,35]. In addi-
tion, sarcolipin— an endogenous peptide inhibitor of SERCA1—has a markedly increased
level in STIM1 defective myotubes, sarcolipin, therefore, also contributes to the reduction in
SOCE and thus delays myotube development [35]. As we pointed out earlier, the SERCA1b iso-
form is probably responsible for most of the SERCA1 (in myotubes [4]). Recently Lee et al. re-
ported that STIM1 binds to SERCA1a and stimulates its activity in rabbit skeletal muscle and
in primary mouse myotubes [17]. Such binding can only happen to a peptide sequence that
Numbers in parentheses indicate the number of cells measured. Asterisks (*) mark significant
(P<0.05) differences.
doi:10.1371/journal.pone.0123583.g006
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Fig 7. Effect of decreased SERCA1b expression on proliferation and differentiation of C2C12 cells. Immunocytochemical staining of terminally
differentiated C2C12 myotubes demonstrating the morphological changes (C) in cloneC1 compared to (A) scrambled shRNA transfected cells. Muscle
specific desmin was detected and visualized with FITC-conjugated secondary antibody. Nuclei were stained with DAPI. Images were recorded from1 μm
thick optical slices. Original magnification was 40×. (E) Proliferation rate was calculated from the increase in the number of myogenic nuclei after normalising
to the value obtained after 24 hours of culturing. Data represent mean ± standard error of the mean (SEM). (B,D, and F) Quantitative parameters of
differentiated multinucleated myotubes.CloneC1 and scrambled shRNA transfected cells were compared. Numbers in parentheses indicate the number of
identified myotubes on 3 different coverslips. Asterisks (*) mark significant (P<0.01) differences.
doi:10.1371/journal.pone.0123583.g007
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must also be present in SERCA1b since SERCA1b contains the entire sequence of SERCA1a ex-
cept the C-terminal glycine [3]. Generating an antibody is not feasible against a C-terminal gly-
cine since it can be present in many other proteins besides SERCA1a. However, Lee et al. [17]
claim to identify SERCA1a by an antibody that was otherwise specified by the source company
as a SERCA1 antibody (recognizing both SERCA1a and SERCA1b) Lee et al. [17]therefore
might well have demonstrated the STIM1 effect on SERCA1b, because they worked with pri-
mary mouse myotubes that probably have SERCA1b as the main SERCA1 isoform. Anyway
the present work is in agreement with the importance of SERCA1b in SOCE because the level
of the calcium sensor STIM1 was decreased in SERCA1b silenced myotubes. It is a general ob-
servation that elements of SOCE are regulated by a positive feedback during myotube develop-
ment, i.e., decreased or increased levels of NFAT isoforms (NFATc1-c4) are paralleled by
decreased or increased levels of STIM1 and Orai1 [7,35,36]. It is worth noting that the STIM1--
knockdown primary mouse myotubes also had decreased SERCA1 activity [17]. It is, therefore,
feasible to suggest that the lower level of STIM1 and SERCA1b generates lower rate of Ca2+
movement across the myoplasm which in turn stimulates less calcineurin and results in re-
duced downstream gene activity reported by the MCIP1.4 mRNA level. Similarly, the silenced
SERCA1b could fill the SR to a lower Ca2+ level requiring, therefore, a lesser amount of CSQ
for storage. On the other hand, the silencing did not modify the myogenic transcription factor
MyoD level suggesting that SERCA1b itself is not directly coupled to MyoD in the myogenic
differentiation. This is in agreement with the observation that the expression of MyoD is
started earlier (in myoblasts, [37]) than that of SERCA1b (in myotubes, [4]) during the
Fig 8. Summarized model showing the role of SERCA1b, in the regulation of calcium homeostasis. Application of shRNA interfering with the
SERCA1b expression resulted in a lower Ca2+-content of the SR and suppressed Ca2+-release into the myoplasm. In turn the activity of calcineurin- a
calcium-dependent protein phosphatase which induces the translocation of the transcription factors of the NFAT family into the nucleus-was attenuated. The
reduced proliferation and differentiation capability of myoblasts could therefore be attributed to a decreased activation of muscle specific genes under the
control of NFAT.
doi:10.1371/journal.pone.0123583.g008
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differentiation of C2C12 cells. However, the reduced transcript level of myostatin in cloneC1
cells suggest a positive interaction with SERCA1b expression. Although myostatin has not
been reported to be directly related to SOCE, our recent findings with hypermuscular mice
[38] suggest that this compact phenotype may be correlated with altered SOCE. We can thus
assume that the decreased level of this factor occurs as part of the mechanism of myotube
growth attenuation.
To examine the effects of SERCA1b silencing on excitation-contraction coupling, repeated
Ca2+ transients were evoked. Neither the amplitude nor the rate of raise of the transients in clo-
neC1 myotubes was different from those measured in the scrambled control cells indicating
that the function of RyR and the voltage-gated channels was not likely affected. Exposure to
high K+ concentration triggered similar Ca2+ elevations in the sarcoplasmic space of both SER-
CA1b silenced and non-silenced myotubes. This indicates that both cell types have a developed
SR filled up to some extent with calcium [39]. Noteworthy in this context that the calcium was
evidently reuptaken into the SR even in the SERCA1b silenced myotubes indicating that other
SERCA pumps (most probably SERCA2a) also take part in this process. However, as it is con-
cluded from the relative time and the extracted maximal uptake capacity, the SERCA1b si-
lenced myotubes restored the sarcoplasmic calcium back to the normal level much slower. This
indicates that SERCA2a, the only other intact high capacity Ca2+pump, is not capable of nor-
mally restoring the sarcoplasmic calcium level by itself without the neonatal Ca2+ pump; there-
fore the SERCA1b is also essential in maintaining normal reuptake speed in these myotubes.
On the other hand, the relatively normal Ca2+ elevation in the sarcoplasm and the slower
Ca2+ removal from the sarcoplasm in silenced myotubes could not be reconciled without as-
suming a decreased amount of released Ca2+ into the sarcoplasmic space and without a lower
Ca2+ influx, which was indeed found. These parameters together enlighten a lower releasable
SR Ca2+ content in silenced than in control myotubes. This suggests that SERCA1b significant-
ly contributes to the refilling of the SR with normal amounts of calcium. Similar results have
been obtained in SERCA1 knock-out mice (where neither SERCA1a nor SERCA1b is express-
ed), namely, the Ca2+ reuptake was slower. [12] As a consequence [12] the contractile force
was lower in the diaphragm and in the hind limb muscles, while SERCA2a expression was also
not changed in compensation to the ablation of SERCA1 [12]. It is noteworthy in this context
that 1–5 hours after birth, when SERCA1 knock-out mice usually die, SERCA1b is still the
dominantly expressed isoform in the corresponding muscles of wild type mice [4]. The changes
in the Ca2+ homeostasis of SERCA1b silenced C2C12 cells is also in agreement with the sugges-
tion that the lack of the neonatal Ca2+ pump might be responsible for the effects seen in
SERCA1 KOmice. Cell proliferation is sensitively connected to SOCE and SERCA (reviewed
by [40,41]). In accordance, the more (cloneC1) and even the less (cloneC5) efficiently silenced
cells showed inhibited muscle cell proliferation and fewer myogenic nuclei in their cultures as
compared to that of control cells. The necessity of SERCA1b for cell proliferation seems to be
connected to calcineurin regulated signaling pathway since CSA, a calcineurin inhibitor, de-
creased cell proliferation in the parental non-transfected cells, but surprisingly no further de-
crease of proliferation was observed in the most silenced clone (cloneC1). It should be noted
here, that the specificity of CSA to calcineurin can be cell type dependent as it can enhance
neuronal cell survivor ([42]) but it can induce nephrotoxicity in a calcineurin independent way
([43]). CSA have been used as a potent calcineurin inhibitor in osteoblast cell line ([44]) or in
chondrogenic cell cultures ([45]). Furthermore, it has been discussed that the inhibition of cal-
cineurin with CSA can modulate the phenotype of muscles ([46]). Moreover, calcineurin can
modulate the proliferation of smooth muscle cells ([47]) and the inhibition with CSA reduce
the proliferation ratio of chondrogenic cells ([48]). This is in line with the observations that
CSA abolished slow muscle differentiation and regeneration and, to a lesser extent, myoblast
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proliferation [49,50]. Our finding that CSA did not inhibit the proliferation in SERCA1b si-
lenced myogenic cell lines suggests that either the CSA-dependent component of calcineurin
activity was mostly based on SERCA1b activity or raise the possibility of a calcineurin indepen-
dent CSA effect.
Difference between myotube nuclear numbers of the most silenced cell line and of the one
transfected with scrambled oligos was also significant. A similar result was obtained in an earli-
er work [51] when thapsigargin, a potent SERCA inhibitor was added to the medium of C2C12
cells and this treatment reduced the rate of myogenic differentiation. Myotube formation is
based on the density of myoblasts in a certain field. First the primary myotubes are formed
with 4–6 nuclei then the secondary myotubes develop further accumulating nuclei from fusing
myoblasts preferably at their end [52]. SERCA1b silenced myotubes (cloneC1) show a strong
incline of having less than five nuclei. This suggested a relatively undisturbed primary myotube
formation and an inhibited secondary myotube development. This is in agreement with our
previous results that BC3H1 myogenic cells that are reluctant to form long (secondary) myo-
tubes with more than four nuclei are not expressing SERCA1b, only SERCA1a [4]. The result
also demonstrates that SERCA2a alone is not able to compensate completely for the declined
(cloneC5) or abolished (cloneC1) SERCA1b in myoblast proliferation, only for the SERCA1b
decline (cloneC5) in myotube development. SERCA2a the only other high capacity SR calcium
pump in myogenic cells [53] may also show an increasing expression in C2C12 differentiation
[54]. Therefore the neonatal SR calcium pump seems to be more important for myoblast prolif-
eration and secondary myotube formation than for primary myotube development.
In summary, SERCA1b is required for myoblast proliferation and secondary myotube for-
mation in murine C2C12 myogenic cells by having an important role in Ca2+ homeostasis (Fig
7). During this process its expression is coupled to those of STIM1, CSQ, and calcineurin sug-
gesting a role in SOCE, too.
Supporting Information
S1 Fig. Localization of SERCA1b specific shRNA (A) corresponding to the mRNA ofmus
musculus SR ATPase.Quantitative analysis of Western-blot experiments. (B) Quantified ex-
pression of SERCA1b in specific shRNA transfected C2C12 clones. (C-F) Quantified expres-
sion of proteins involved in Ca2+-homeostasis and differentiation of skeletal muscle. CloneC1,
C5, and scrambled shRNA transfected control cells were compared to parental cells in each
cases. Asterisks () indicate significant (p< 0.05) differences. Representative data of 3
independent experiments.
(DOCX)
S2 Fig. mRNA expression pattern of MSTN and MCIP1.4 were detected by RT-PCR. (A, B)
Pooled data represent integrated optical densities of signals determined by ImageJ after nor-
malizing to GAPDH as a control (C) Proliferation rate as calculated from the increase in the
number of myogenic nuclei normalised to the value obtained after 24h culturing duration,
when the cells were treated with 200 nM CSA. Data represent mean ± standard error of the
mean (SEM). Data for parental and cloneC1 without CSA treatment are also presented at 125th
hour of culturing. (D) Expression pattern of SERCA2a in cloneC1, C5, scrambled shRNA
transfected, and parental C2C12 cells. Actin was used as loading, while lysate from adult
mouse heart was used as expression control. (E) Quantitative analysis of SERCA2a expression,
transfected cells were compared to parental cells. (F) Expression pattern of voltage dependent
calcium channel (Cav pan α1 subunit) in cloneC1, C5, scrambled shRNA transfected, and pa-
rental C2C12 cells. Reference figure of Alomone Labs is also attached. Representative data of 3
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independent experiments.
(DOCX)
S1 Raw Data. Raw data of densitometric analysis of Western-blot experiments. Quantifica-
tion of bands referring to the detected proteins was performed with ImageJ.
(XLSX)
S2 Raw Data. Raw data of single cell fluorescent Ca2+-measurements. Ca2+ transients were
evoked by repeated KCl-depolarization. To analyze the functional effects of decreased SER-
CA1b expression, the return of [Ca2+]i to its resting value following the KCl-evoked transients
and the maximal transport rate of the Ca2+ pump (PVmax) were compared. To examine the
Ca2+ content of the SR Ca2+ store the cells were treated with CPA.
(XLSX)
S3 Raw Data. Raw data of calculation of cell proliferation. Cell proliferation was character-
ized by the increase in the number of myogenic nuclei normalized to the value obtained after
24 hours of culturing.
(XLSX)
S4 Raw Data. Raw data of examination of morphology of myotubes. Cultures on the 5th day
of differentiation were fixed, and the number of DAPI-stained nuclei were counted manually,
the diameter was measured by Image Browser.
(XLSX)
S5 Raw Data. Activity of calcineurin was assayed by using RII phosphopeptide substrate,
and the release of free PO4
3- was detected by a classic malachite green assay (Abcam, Cam-
bridge, UK). Six separate wells were used from every single experimental group.
(XLSX)
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